TKK Symphony Acquisition Corporation (TKKS) announced at 8:00 p.m. this evening that it would be extending the expiration of its tender offer to purchase up to 25,000,000 shares at a purchase price of $10.28 (plus accrued interest) for a fifth time. Yes, they went for a fifth extension….. The tender offer will now expire at 5:00 p.m. New York City time, on Monday, February 10, 2020, unless further extended or earlier terminated.
If you’re asking why, well, that’s because rather than work with the results TKKS had at the last deadline, on January 13th, which were much improved (all things considered), instead they decided to extend again to January 23rd, presumably to try and squeeze out a few more non-tenderers. However, this last extension seems to have had the opposite effect. That’s because at the last deadline, only 21,295,878 ordinary shares had been tendered out of 25,000,000, leaving approximately $38 million in trust. However, in the last 10 ten days, investors must have gotten spooked. As of today, 24,560,639 ordinary shares have now been tendered, basically reversing the previously results. That means only 439,361 shares remain for an approximate trust value of $4.5 million.
TKKS is running out of time. Their completion deadline is February 20th, and by continually extending, they’ve tested the patience of investors and now TKKS is in the unfortunate position of having to start from almost square one without a safety net since they’re set to expire in less than four weeks. Is there a possibility they could extend for a sixth time? Well, their new deadline is February 10th, which leaves only 10 days between then and their expiration deadline of February 20th. Technically, it’s possible. But at this point, it would be the equivalent of a Hail Mary. Frankly, forget the fifth extension, the FOURTH extension seemed improbable since if they had $38 million at that point, you don’t give investors more time to change their mind. You close. But we’re not privy to what the conversation is between the SPAC and the seller, so let’s give the team the benefit of the doubt, but clearly $38 million was not enough.
This one is going to be close and the team has their work cut out for them. We have another 18 days to see what happens…stay tuned.
December 2024 corporate actions continues the trend of SPAC teams seeking additional extensions beyond their third round, as they work to close their combinations with the remaining funds after redemptions. Despite this activity, both announcements and corporate actions associated with completion votes were notably few this month. Extension Votes In December, there were 26 scheduled...
At the SPAC of Dawn 2025 dawns with a reminder to SPAC teams that, as the Rolling Stones song goes, “You can’t always get what you want.” That was the message sent by Aimei Health I (NASDAQ:AFJK) shareholders as they rejected a proposal to reduce the SPAC’s monthly contribution to trust for the duration of...
An In-Depth Look at SPAC Activity Throughout the Full-Year of 2024 Below is a summary of the Full-Year 2024 SPAC market. If you’d like a pdf copy, you access the link HERE. SPACs have emerged from 2024 with a cautious optimism that feels both hard-earned and fragile. After weathering the turbulence of the past few...
The next quarter century is starting off with a set of de-SPAC shareholders newly able to realize better gains as their lock-ups expire in January than most months through 2024. Eight de-SPACs and six sponsors are to see their shares unlocked next month, and while none of these companies finished trading on December 30 in...
Maywood Acquisition Corp. (NASDAQ:MAYAU) filed to list a $75 million SPAC on the penultimate day of 2024 with a CEO making his second rodeo and a focus on serving the demand for listing opportunities and exits in Asia-Pacific. This new SPAC is not overfunding its trust and will have rights to a 1/5 share in...